Prevalence and Correlates of Sleep Problems in Children and Adolescents with Type 1 Diabetes: A Cross-Sectional Study

Youssef A Alqahtani1, Ayed A Shati1, Samy A Dawood1

  • 1Department of Child Health, College of Medicine, King Khalid University, Abha, Saudi Arabia.

Insights

Sleep problems are common in children with Type 1 Diabetes Mellitus (T1DM), linked to guardian education, income, glucose control, and household smoking. Addressing these factors is crucial for managing T1DM in pediatric patients.

Area of Science:

  • Pediatric Endocrinology
  • Sleep Medicine
  • Public Health

Background:

  • Sleep disturbances, including nighttime awakenings, negatively impact daily functioning and glycemic control in children with Type 1 Diabetes Mellitus (T1DM).
  • These sleep issues can create a detrimental cycle affecting overall health and adherence to diabetes management.
  • Understanding the factors associated with sleep problems is vital for comprehensive T1DM care in pediatric populations.

Purpose of the Study:

  • To investigate the prevalence of sleep problems in children and adolescents diagnosed with T1DM.
  • To identify significant health-related and sociodemographic correlates of sleep disturbances in this population.
  • To elucidate the complex relationships influencing sleep quality among young T1DM patients.

Main Methods:

  • A cross-sectional study was conducted with 248 children and adolescents (aged 6-18 years) with T1DM in Abha, Saudi Arabia.
  • Data were collected via validated sleep assessments, demographic surveys, and diabetes-related factor evaluations during routine clinic visits.
  • Statistical analysis, including Chi-square tests, was performed using Python to determine associations (P≤0.05).

Main Results:

  • 37.5% of children with T1DM experienced sleep problems, with a mean age of 10-12 years and predominantly male participants (86.29%).
  • Significant associations were found between sleep disturbance and guardian's marital status, education level, household income, glucose levels, testing frequency, and passive smoking exposure.
  • No significant correlation was observed between sleep problems and the insulin administration method or comorbidities.

Conclusions:

  • Sleep problems in children with T1DM are associated with a multifactorial interplay of socioeconomic status, environmental exposures like secondhand smoke, and glycemic control.
  • These findings underscore the necessity of integrating assessments of environmental and socioeconomic factors into the management of T1DM in children.
  • Targeted interventions addressing these correlates may improve sleep quality and overall health outcomes for pediatric T1DM patients.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...